Trazodone is not a narcotic. It is an antidepressant, specifically a serotonin antagonist and reuptake inhibitor (SARI). It is not classified as a controlled substance under the Controlled Substances Act, which means it carries no DEA scheduling and is not in the same legal or pharmacological category as opioids like morphine, oxycodone, or fentanyl.
Why Trazodone Gets Confused With Narcotics
The confusion likely comes from trazodone’s heavy use as a sleep aid. Many people associate sedating medications with narcotics, but sedation alone doesn’t make a drug a narcotic. The term “narcotic” specifically refers to opioids, drugs that bind to opioid receptors in the brain and spinal cord to block pain signals. Think morphine, codeine, hydrocodone. These drugs carry a high risk of physical dependence and are tightly regulated.
Trazodone works through an entirely different system. It affects serotonin, a chemical messenger involved in mood, sleep, and anxiety. At low doses (25 to 100 mg), it blocks certain serotonin receptors along with histamine and adrenaline receptors, which produces drowsiness. That sedating effect is why doctors frequently prescribe it off-label for insomnia, even though it was originally approved in 1981 to treat depression. For depression, much higher doses are needed, typically 150 to 600 mg.
One piece of animal research has shown that trazodone’s pain-relieving effects in mice involve some interaction with mu-opioid receptor pathways. This does not make trazodone an opioid. Many non-opioid substances can indirectly influence these pathways without producing the characteristic opioid effects of euphoria, respiratory depression, or strong physical dependence. The FDA, DEA, and every major pharmacological reference classify trazodone as an antidepressant, not a narcotic.
How Trazodone Differs From Controlled Substances
Controlled substances are ranked on a schedule from I to V based on their potential for abuse and dependence. Schedule II drugs like oxycodone and fentanyl have high abuse potential. Even common sleep medications like zolpidem (Ambien) are Schedule IV. Trazodone sits outside this system entirely. Your pharmacy can fill it without the special prescribing restrictions that apply to controlled substances, and refills don’t require a new prescription each time.
This distinction matters practically. You won’t face the same monitoring, pill counts, or prescription limits that come with narcotic medications. Trazodone also doesn’t produce the euphoric “high” that drives opioid misuse. Its most common side effects lean in the opposite direction: drowsiness, dizziness, and dry mouth.
Trazodone Can Still Cause Dependence
Not being a narcotic doesn’t mean trazodone is free of withdrawal effects. If you take it regularly and stop abruptly, your brain needs time to readjust its serotonin balance. This is called antidepressant discontinuation syndrome, and it can produce a range of symptoms: dizziness, headaches, nausea, fatigue, muscle aches, and disrupted sleep including vivid dreams. Some people experience what are informally called “brain zaps,” brief electric shock sensations that feel startling but aren’t dangerous.
The psychological side can be just as noticeable. Mood swings, increased anxiety, irritability, difficulty concentrating, and a temporary return of depressive symptoms are all common during the adjustment period. These symptoms gradually resolve as the brain re-establishes its natural chemical balance, but they’re the reason doctors recommend tapering off trazodone slowly rather than stopping cold.
This type of discontinuation syndrome is fundamentally different from opioid withdrawal. Opioid withdrawal involves intense drug cravings, a hallmark of addiction. Trazodone discontinuation reflects your nervous system recalibrating, not a compulsive need for the drug.
What Trazodone Is Actually Prescribed For
Trazodone’s only FDA-approved use is for the treatment of major depressive disorder, with or without accompanying anxiety. In practice, its most common use today is as a sleep aid at lower doses. Doctors prescribe it off-label for insomnia because it causes reliable drowsiness without carrying the controlled-substance restrictions of traditional sleep medications. The sedating effect kicks in at doses well below what’s needed for antidepressant benefits, which is why a person taking 50 mg for sleep is on a very different regimen than someone taking 300 mg for depression.
Like all antidepressants, trazodone carries an FDA black box warning about an increased risk of suicidal thoughts and behaviors in people under 25. This warning applies to the entire antidepressant drug class, not to trazodone specifically, and it underscores the importance of close monitoring during the early weeks of treatment.
The Bottom Line on Drug Testing
Because trazodone is not a narcotic or controlled substance, standard drug tests don’t screen for it. It will not cause a positive result for opioids. In rare cases, trazodone has been reported to trigger a false positive for amphetamines on certain immunoassay urine screens, but a confirmatory test will quickly rule that out. If you’re concerned about a drug test, knowing that trazodone is pharmacologically unrelated to narcotics should offer some reassurance.